Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

BioNTech, CureVac, EXMceuticals - reaching their goal with government support

In the fight against the spread of the Corona Pandemic, a great deal of commitment is required from companies. This situation also offers the opportunity to rethink and change existing work processes and procedures. Product ranges are being expanded and new possibilities and a...

Currency Wars Are Wars That Gold Wins in the End

July nonfarm payrolls came in line with expectations, confirming the strength of the U.S. labor market. So far so good. With the markets more focused now on the escalation of the trade war triggered by Trump’s tweet on Thursday., she stock market plunged while ...

BioNTech, CureVac, Valeo Pharma - Growth after capital injection

Anyone working in the medical sector knows that the development of therapies and products usually costs a lot of time and especially a lot of money. In the race against the spread of the current Corona pandemic, there are major changes in the industry, because whoever comes to...

Small-Cap Pharma Fast-Tracking Repurposed Drug for Covid-19

Algernon Pharmaceuticals is quickly moving ahead with a multinational Phase 2b/3 trial for Ifenprodil. Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW:FSE) , a Canada-based clinical stage drug development company that focuses on drug repurposing, believes ...

COVID Hits Mining Companies

Franco-Nevada Corp. (FNV:TSX; FNV:NYSE, US$113.69) , following most of its royalty peers, pulled its guidance for both GEOs (gold-equivalent ounces) and energy. Cobre Panama, which had been ramping up well and accounted for 15–20% of its previous 2020 guidance, has shut d...

Unnatural Distortions and the Precious Metals

I was sitting in my den looking out over the swamp—er—lake tonight when it appeared as though something was flailing around near the shoreline. So I threw on my deck shoes and went for a stroll down to the water to see what all the commotion was about. Now, you must under...

Construction Pipeline Shows Undervalued Opportunity

This Vancouver Construction Company Continues to Trade Undervalued with a Long List of Projects in the Pipeline. A Vancouver-based general contracting company, with a list of international jobs in the pipeline, is trading for just eight cents apiece right now. From ea...

The Critical Investor Interviews Joe Grosso, CEO of Golden Arrow Resources

The Critical Investor sits down with Joe Grosso, CEO of Golden Arrow Resources, to discuss the company's exploration plans for the new year. 1. Introduction At a time when tax loss selling is at its peak, Golden Arrow Resources Corp. (GRG:TSX.V; GARWF:OTCQB;...

Crude Cuts Get Another Saudi Boost as Oil Demand Begins to Show Signs of Life

Saudi Arabia enhanced their commitment to OPEC+ supply cuts as the Kingdom said they'd shut production of additional 1 million barrels of crude oil per day next month. Most of the OPEC+ countries have already come close to compliance with the deal that took effect this mo...

Canadian Explorer Unearths 'Blockbuster Grades'; Still Has 'Room to Run'

The Golden Triangle (GT) of northwestern British Columbia has been one of the best performing mining districts for precious and base metals juniors. Of roughly 30 names I'm tracking, as of the close on June 30, the Top 3 are up an average of +1,536% (!) from their re...
1 2 3 4 5 6 7 8 9 10 ...